Grudiz Tablet 2.5 mg (Letrozole)

What is Grudiz Tablet & How it Works

Grudiz contains the active ingredient letrozole, which belongs to the class of arromatase inhibitors. It helps reduce estrogen production in postmenopausal women, thereby slowing or stopping the growth of hormone-receptor positive breast cancer cells that depend on estrogen to grow.

Because many breast cancer cells need estrogen to proliferate, by limiting estrogen availability, Grudiz helps deprive them of a fuel source. It can be used in various treatment strategies—after initial therapy, in extended settings, or in advanced disease management.

---

Grudiz Tablet Uses & Indications

Grudiz (Letrozole 2.5 mg) is indicated in postmenopausal women for:

• Adjuvant treatment of hormone receptor–positive early invasive breast cancer

• Extended adjuvant therapy in women who have completed 5 years of tamoxifen therapy

• First-line therapy in hormone-dependent advanced or metastatic breast cancer

• After relapse or disease progression in women previously treated with anti-oestrogens

• Neoadjuvant therapy (prior to surgery) in selected patients when chemotherapy is not suitable

Important Note: Grudiz has not been shown effective in hormone receptor–negative breast cancers.

---

Dosage & Administration

• The typical dose is 2.5 mg once daily, taken orally (with or without food)

• In adjuvant or extended-adjuvant settings, treatment is usually continued for up to five years (or until relapse)

• In neoadjuvant use, treatment may be given for 4 to 8 months to achieve optimal tumor shrinkage

• No dose adjustment is generally required for elderly patients, or for patients with mild to moderate renal or hepatic impairment (Child-Pugh A or B)

• If a dose is missed and it’s more than 2–3 hours until the next dose, skip the missed dose (do not double up)

• For Infertility the recommended starting dose should be 2.5 mg daily for 5 days, starting from day 2 of menstrual cycle.

---

Side Effects & Safety Profile

Like all potent hormonal therapies, Grudiz has a profile of possible side effects. Most are mild to moderate and may subside over time as the body adjusts.

Common Side Effects

• Hot flashes / sweating bouts

• Joint pain / muscle aches (arthralgia, myalgia)

• Fatigue / weakness

• Increased cholesterol levels

• Hair thinning or hair loss

• Gastrointestinal complaints: nausea, indigestion, diarrhea or constipation

• Vaginal bleeding or dryness

• Dizziness, headache

• Weight changes, edema (swelling of limbs)

• Mood changes, depression

Less Common or Serious Risks

• Bone density loss / osteoporosis — long-term estrogen suppression may weaken bones; monitoring and prophylaxis may be needed.

• Tendonitis or tendon rupture (rare)

• Liver enzyme alterations

• Allergic reactions (rash, swelling)

• Blood clot risk, though rare

• Severe symptoms such as chest pain, sudden limb pain, signs of stroke or organ damage — these demand immediate medical attention

Important Warnings:

• Use only in postmenopausal women; contraindicated in premenopausal status, pregnancy, or breastfeeding.

• Caution in patients with existing osteoporosis or fracture risk

• Co-administration with tamoxifen or estrogen therapies should be avoided, as they may reduce letrozole’s effect.

• Monitor kidney or severe hepatic impairment cases more closely

---

Storage & Handling

• Store in a cool, dry place below 30 °C, protected from heat, light, and moisture

• Keep out of reach of children

• Use only until the expiration date printed on the pack

• Dispose of unused medicine properly (consult your pharmacist)

---

Grudiz Tablet Price In Pakistan & Availability

According to local pricing sources, Grudiz 2.5 mg (10 tablets) can be priced around Rs. 2000 PKR per pack containing 10 pills in some Pakistani markets.

---

Why Choose Grudiz?

• Manufactured by SAMI Pharmaceuticals, a trusted name in Pakistan’s pharmaceutical sector.

• Designed and formulated to match international standards of safety and efficacy

• A cost-effective local alternative to international brands

• Easy once-daily dosing with no frequent adjustments needed

---

Note to Patients & Caregivers:
Grudiz is a prescription-only medication. It should be taken strictly under medical supervision, with periodic monitoring (bone density tests, lipid profile, liver function) as advised by your oncologist or physician. If you experience troublesome or persistent side effects, or symptoms that suggest complications, seek medical attention immediately.

---

Suggested Products:

• Compare with Lezra 2.5

• Also explore Aromek 2.5

• See alternatives like Lets 2.5